Dr Marisa López-Teijón, creator of the BabyPod technological device and CEO of Institut Marquès, a global benchmark in assisted reproduction and CataloniaBio & HealthTech member, is looking for investors to tackle the next phases of the R&D project. 

BabyPod is the first small-format intravaginal device that uses music to stimulate vocalisation of babies before birth. The product was created through a line of research conducted by Dr López-Teijón on the effects of music from the beginning of life, which has conducted several scientific studies and been recognised by Harvard University and the Massachusetts Institute of Technology (MIT).

The product is patented internationally and has gained FDA approval in the United States as a wellness device (non-medical), which makes it easier for it to break into that market.

“After the media impact BabyPod has had with the first generation of the product, we are looking for investors to collaborate on the next phase, which is to boost international marketing and make improvements to the product,” explains project leader Antonio Navarro. 

The company currently has distribution deals in China, Eastern Europe and Mercosur.

More information:
eloy.ruiz@institutomarques.com